Market News
![Cabaletta Bio, Inc. (NASDAQ:CABA) Given Consensus Rating of “Buy” by Brokerages - Zolmax](https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?src=https://www.marketbeat.com/logos/cabaletta-bio-inc-logo-1200x675.png?v=20240515131150&w=240&h=240&zc=2)
Cabaletta Bio, Inc. (NASDAQ:CABA) Given Consensus Rating of “Buy” by Brokerages - Zolmax
- zolmax.com
- July 27, 2024
![Blue Bird Co. (NASDAQ:BLBD) Given Average Recommendation of “Buy” by Analysts - Zolmax](https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?src=https://www.marketbeat.com/logos/blue-bird-corporation-logo-1200x675.png&w=240&h=240&zc=2)
Blue Bird Co. (NASDAQ:BLBD) Given Average Recommendation of “Buy” by Analysts - Zolmax
- zolmax.com
- July 27, 2024
- {{ news.topicsByEntity.length > 0 ? news.topicsByEntity[0].name : '' }}
{{ processTitle(news.title) }}
- {{news.provider}}
- {{ dateToMDY(news.publishDate) }}
- Read More